Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas

ASIAIR > College of Medical and Health Science > Department of Food Nutrition and Healthy Biotechnology > Journal Article > Item 310904400/112914

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/112914

Title:	Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas
Authors:	張家崙;Chang, Chia-Lun;袁聖博;Yuan, Kevin Sheng-Po;吳駿翃;Wu, Alexander T.H.;吳思遠;Wu, Szu-Yuan
Contributors:	食品營養與保健生技學系
Keywords:	Fractionated radiotherapy;Nonfunctioning pituitary macroadenoma;Stereotactic radiosurgery;StrokeToxicity;Transsphenoidal surgery
Date:	2019-11
Issue Date:	2020-09-03 07:21:20 (UTC+0)
Publisher:	亞洲大學
Abstract:	Background: Here, we compared the toxicity profiles of contemporary stereotactic radiosurgery (SRS), modern fractionated radiotherapy (FRT), and transsphenoidal surgery used to treat non functioning pituitary macroadenomas. Methods: We included the data of patients with non functioning pituitary macroadenomas. To compare treatment outcomes, the patients were categorized groups 1 (those receiving modern FRT), 2 (those receiving contemporary SRS), and 3 (those receiving transsphenoidal surgery). The multivariable Cox proportional hazards regression analysis was performed to yielded adjusted hazard ratios (aHRs) and their 95% CIs for local recurrence in groups 2 and 3 compared with group 1. Results: We included the data of 248 patients with non functioning pituitary macroadenomas. The analytical results revealed no significant differences in second primary brain or head and neck cancer, hypopituitarism, or optic nerve injury between the three cohorts. The multivariable Cox proportional hazards regression analysis revealed that compared with group 1, the aHRs (95% CIs) for stroke risk in groups 2 and 3 were 0.37 (0.14–0.99) and 0.51 (0.31–0.84), respectively. Conclusion: Contemporary SRS and transsphenoidal surgery for non functioning pituitary macroadenoma treatment have equivalent toxicity profiles. However, modern FRT for non functioning pituitary macroadenoma treatment might considerably increase stroke risk.
Relation:	Cancers
Appears in Collections:	[Department of Food Nutrition and Healthy Biotechnology] Journal Article

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	250	View/Open

View Licence

Loading...